A double-blind, randomised parallel group study to compare the efficacy and safety of cefuroxime plus erythromycin in the treatment of patients with community-acquired pneumonia

ISRCTN	ISRCTN47137942
DOI	https://doi.org/10.1186/ISRCTN47137942
Protocol serial number	RDC00079
Sponsor	NHS R&D Regional Programme Register - Department of Health (UK)
Funder	NHS Executive London (UK)

Prospectively registered

Protocol

Statistical analysis plan

Results

Individual participant data

Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Dr John Moore-Gillon
Scientific

St Bartholomew's Hospital Medical College
St Bartholomew's hospital
West Smithfield
London
EC1 7BE
United Kingdom

Primary study design	Interventional
Study design	Double-blind randomised parallel group study
Secondary study design	Randomised controlled trial
Scientific title
Study objectives	Not provided at time of registration
Ethics approval(s)	Not provided at time of registration
Health condition(s) or problem(s) studied	Respiratory tract diseases: Other respiratory tract disease
Intervention	Not provided at time of registration
Intervention type	Other
Primary outcome measure(s)	Not provided at time of registration
Key secondary outcome measure(s)	Not provided at time of registration
Completion date	31/01/2003

Participant type(s)	Patient
Age group	Not Specified
Sex	Not Specified
Key inclusion criteria	Not provided at time of registration
Key exclusion criteria	Not provided at time of registration
Date of first enrolment	10/01/2001
Date of final enrolment	31/01/2003

St Bartholomew's Hospital Medical College

London
EC1 7BE
United Kingdom

Individual participant data (IPD) Intention to share	No
IPD sharing plan summary	Not provided at time of registration
IPD sharing plan